Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Non-Invasive Diagnostic Technologies for Skin Disease Management

Description

The discussion focuses on non-invasive diagnostic technologies in skin disease management, highlighting the shortcomings of traditional histology, which has remained largely unchanged for over 155 years. With more than 90% of skin biopsy results returning benign, there's a need for innovative alternatives. The presentation introduces several non-invasive methods, particularly confocal microscopy, which allows for real-time, high-resolution imaging of skin lesions without the need for biopsies. Other technologies discussed include optical coherence tomography (OCT) and line field optical coherence tomography (LCOCT), which provide additional imaging capabilities and are easier to use. These advancements are particularly beneficial for diagnosing various skin cancers and inflammatory skin conditions, as well as for monitoring treatment efficacy, such as in cases of melasma and acne. Despite their potential, these technologies face challenges including cost, training needs, and limited reimbursement options. The presentation concludes by discussing the importance of proper billing practices and the possibility of leveraging CPT codes for confocal microscopy to ensure financial sustainability in clinical practice.

View more

Conclusions

  • The majority of skin biopsies yield benign results, indicating a need for more efficient diagnostic methods.
  • Non-invasive imaging techniques can reduce unnecessary biopsies and their associated psychosocial impacts.
  • Confocal microscopy provides real-time, high-resolution images of skin lesions, improving diagnostic accuracy.
  • Line-field optical coherence tomography (LC-OCT) combines the advantages of RCM and OCT, allowing for detailed imaging of skin structures.
  • Multiphoton microscopy offers near-histopathological resolution and is useful in assessing skin cancers and treatment effects.
  • Integration of these technologies into clinical practice can enhance patient outcomes and minimize invasive procedures.
  • Training and cost are barriers to the widespread adoption of advanced non-invasive imaging techniques.
  • Wissowzky. 1876. The combination of the hematoxylin and eosin (H&E) dyes was first used to stain tissues.
  • Chuchvara N, Reilly C, Srivastava R, Haroon A, Rao B. Cost-benefit analysis of traditional biopsy pathway vs noninvasive diagnostic techniques for suspected skin malignancies. Volume 83, Issue 6, Supplement AB142, December 2020.
  • Pena AM, Baldeweck T, Decencière E, et al. In vivo multiphoton multiparametric 3D quantification of human skin aging on forearm and face. Sci Rep 12, 14863 (2022). https://doi.org/10.1038/s41598-022-18657-z
  • Guitera P, Pellacani G, Crotty KA, et al. The impact of in vivo reflectance confocal microscopy on the diagnostic accuracy of lentigo maligna and equivocal pigmented and nonpigmented macules of the face. J Invest Dermatol. 2010;130(8):2080-2091.
  • Edwards SJ, Osei-Assibey G, Patalay R, et al. Diagnostic accuracy of reflectance confocal microscopy using VivaScope for detecting and monitoring skin lesions: a systematic review. Clin Exp Dermatol. 2017;42:266-275.
  • Ogien J, Tavernier C, Fischman S, Dubois A. Line-field confocal optical coherence tomography (LC-OCT): principles and practical use. Ital J Dermatol Venerol. 2023 Jun;158(3):171-179. doi: 10.23736/S2784-8671.23.07613-2.
  • Themstrup L, Pellacani G, Welzel J, Holmes J, Jemec GBE, Ulrich M. In vivo microvascular imaging of normal skin and from squamous cell carcinoma using dynamic optical coherence tomography. J Eur Acad Dermatol Venereol. 2016;30(11):1919-1925. doi: 10.1111/jdv.13704.
  • Balu M, Zachary CB, Harris RM, et al. In Vivo Multiphoton Microscopy of Basal Cell Carcinoma. JAMA Dermatol. 2015;151(10):1068-1074. doi:10.1001/jamadermatol.2015.0453.
  • Perez-Anker J, Soglia S, Lenoir C, Albero R, Alos L, García A, et al. Criteria for melanocytic lesions in LC-OCT. Eur Acad Dermatol Venereol. 2024;38:2005-2016. https://doi.org/10.1111/jdv.20079.